Annual Revenue
$96.73 M
+$48.16 M+99.13%
December 31, 2023
Summary
- As of February 8, 2025, SPRO annual revenue is $96.73 million, with the most recent change of +$48.16 million (+99.13%) on December 31, 2023.
- During the last 3 years, SPRO annual revenue has risen by +$96.48 million (+37394.19%).
- SPRO annual revenue is now at all-time high.
Performance
SPRO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$7.82 M
+$1.80 M+29.95%
September 30, 2024
Summary
- As of February 8, 2025, SPRO quarterly revenue is $7.82 million, with the most recent change of +$1.80 million (+29.95%) on September 30, 2024.
- Over the past year, SPRO quarterly revenue has dropped by -$64.01 million (-89.11%).
- SPRO quarterly revenue is now -89.11% below its all-time high of $71.83 million, reached on December 31, 2023.
Performance
SPRO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$89.86 M
-$15.56 M-14.76%
September 30, 2024
Summary
- As of February 8, 2025, SPRO TTM revenue is $89.86 million, with the most recent change of -$15.56 million (-14.76%) on September 30, 2024.
- Over the past year, SPRO TTM revenue has dropped by -$6.87 million (-7.10%).
- SPRO TTM revenue is now -14.76% below its all-time high of $105.43 million, reached on June 30, 2024.
Performance
SPRO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
SPRO Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +99.1% | -89.1% | -7.1% |
| 3 y3 years | +10000.0% | -89.1% | -7.1% |
| 5 y5 years | +2339.1% | -89.1% | -7.1% |
SPRO Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3051.0% | -89.1% | +3065.6% | -14.8% | +4165.1% |
| 5 y | 5-year | at high | >+9999.0% | -89.1% | +180.0% | -14.8% | +2165.4% |
| alltime | all time | at high | >+9999.0% | -89.1% | +180.0% | -14.8% | +2165.4% |
Spero Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $7.82 M(+29.9%) | $89.86 M(-14.8%) |
| Jun 2024 | - | $6.02 M(+43.1%) | $105.43 M(+5.2%) |
| Mar 2024 | - | $4.20 M(-94.1%) | $100.20 M(+3.6%) |
| Dec 2023 | $96.73 M(+99.1%) | $71.83 M(+207.2%) | $96.73 M(+35.7%) |
| Sep 2023 | - | $23.38 M(+2867.3%) | $71.26 M(+45.5%) |
| Jun 2023 | - | $788.00 K(+6.5%) | $48.96 M(-0.2%) |
| Mar 2023 | - | $740.00 K(-98.4%) | $49.07 M(+1.0%) |
| Dec 2022 | $48.58 M(+1482.4%) | $46.35 M(+4184.1%) | $48.58 M(+1858.0%) |
| Sep 2022 | - | $1.08 M(+20.8%) | $2.48 M(+17.8%) |
| Jun 2022 | - | $896.00 K(+262.8%) | $2.11 M(-36.5%) |
| Mar 2022 | - | $247.00 K(-3.5%) | $3.32 M(+8.0%) |
| Dec 2021 | $3.07 M(+1089.9%) | $256.00 K(-63.8%) | $3.07 M(-170.6%) |
| Sep 2021 | - | $708.00 K(-66.4%) | -$4.35 M(+308.9%) |
| Jun 2021 | - | $2.11 M(-129.4%) | -$1.06 M(-512.4%) |
| Dec 2020 | $258.00 K | -$7.17 M(-279.3%) | $258.00 K(-111.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $4.00 M(+131.3%) | -$2.35 M(+38.0%) |
| Jun 2020 | - | $1.73 M(+1.5%) | -$1.70 M(+33.6%) |
| Mar 2020 | - | $1.70 M(-117.4%) | -$1.27 M(-253.4%) |
| Dec 2019 | $4.74 M(+19.6%) | -$9.78 M(-310.5%) | $831.00 K(-92.2%) |
| Sep 2019 | - | $4.64 M(+115.4%) | $10.61 M(+77.9%) |
| Jun 2019 | - | $2.16 M(-43.4%) | $5.96 M(+39.6%) |
| Mar 2019 | - | $3.81 M(+722.2%) | $4.27 M(+33.2%) |
| Dec 2018 | $3.97 M(+100.4%) | - | - |
| Jun 2018 | - | $463.00 K(-59.8%) | $3.21 M(+7.2%) |
| Mar 2018 | - | $1.15 M(+16.1%) | $2.99 M(+51.2%) |
| Dec 2017 | $1.98 M(+490.7%) | $993.00 K(+66.3%) | $1.98 M(+49.8%) |
| Sep 2017 | - | $597.00 K(+139.8%) | $1.32 M(+82.5%) |
| Jun 2017 | - | $249.00 K(+77.9%) | $724.00 K(+52.4%) |
| Mar 2017 | - | $140.00 K(-58.2%) | $475.00 K(+41.8%) |
| Dec 2016 | $335.00 K | $335.00 K | $335.00 K |
FAQ
- What is Spero Therapeutics annual revenue?
- What is the all time high annual revenue for Spero Therapeutics?
- What is Spero Therapeutics annual revenue year-on-year change?
- What is Spero Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Spero Therapeutics?
- What is Spero Therapeutics quarterly revenue year-on-year change?
- What is Spero Therapeutics TTM revenue?
- What is the all time high TTM revenue for Spero Therapeutics?
- What is Spero Therapeutics TTM revenue year-on-year change?
What is Spero Therapeutics annual revenue?
The current annual revenue of SPRO is $96.73 M
What is the all time high annual revenue for Spero Therapeutics?
Spero Therapeutics all-time high annual revenue is $96.73 M
What is Spero Therapeutics annual revenue year-on-year change?
Over the past year, SPRO annual revenue has changed by +$48.16 M (+99.13%)
What is Spero Therapeutics quarterly revenue?
The current quarterly revenue of SPRO is $7.82 M
What is the all time high quarterly revenue for Spero Therapeutics?
Spero Therapeutics all-time high quarterly revenue is $71.83 M
What is Spero Therapeutics quarterly revenue year-on-year change?
Over the past year, SPRO quarterly revenue has changed by -$64.01 M (-89.11%)
What is Spero Therapeutics TTM revenue?
The current TTM revenue of SPRO is $89.86 M
What is the all time high TTM revenue for Spero Therapeutics?
Spero Therapeutics all-time high TTM revenue is $105.43 M
What is Spero Therapeutics TTM revenue year-on-year change?
Over the past year, SPRO TTM revenue has changed by -$6.87 M (-7.10%)